XNCR
Xencor, Inc.
NASDAQ · Healthcare · Biotechnology · US
$26.61
−0.04%0
Insider buys (3m)
5
Insider sells (3m)
-$379.1K
Net value (3m)
+125.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 8, 2026 | GUSTAFSON KURT A · director | A-Award | 20,604 | $12 |
| Jul 8, 2026 | Deshaies Raymond Joseph · director | A-Award | 10,302 | $0.00 |
| Jul 8, 2026 | SIMPSON TODD E · director | A-Award | 10,302 | $0.00 |
| Jul 8, 2026 | GUSTAFSON KURT A · director | A-Award | 10,302 | $0.00 |
| Jul 8, 2026 | GORMAN KEVIN CHARLES · director | A-Award | 10,302 | $0.00 |
| Jul 8, 2026 | Klencke Barbara · director | A-Award | 20,604 | $12 |
| Jul 8, 2026 | Feigal Ellen · director | A-Award | 20,604 | $12 |
| Jul 8, 2026 | Montgomery Alan Bruce · director | A-Award | 20,604 | $12 |
| Jul 8, 2026 | SIMPSON TODD E · director | A-Award | 20,604 | $12 |
| Jul 8, 2026 | RANIERI RICHARD J · director | A-Award | 20,604 | $12 |
| Jul 8, 2026 | Feigal Ellen · director | A-Award | 10,302 | $0.00 |
| Jul 8, 2026 | RANIERI RICHARD J · director | A-Award | 10,302 | $0.00 |
| Jul 8, 2026 | Montgomery Alan Bruce · director | A-Award | 10,302 | $0.00 |
| Jul 8, 2026 | GORMAN KEVIN CHARLES · director | A-Award | 20,604 | $12 |
| Jul 8, 2026 | Klencke Barbara · director | A-Award | 10,302 | $0.00 |
| Jul 8, 2026 | Deshaies Raymond Joseph · director | A-Award | 20,604 | $12 |
| Jun 22, 2026 | Feigal Ellen · director | Sale | 6,843 | $13 |
| Jun 17, 2026 | Montgomery Alan Bruce · director | Sale | 5,064 | $12 |
| Jun 17, 2026 | GUSTAFSON KURT A · director | Sale | 5,474 | $12 |
| Jun 17, 2026 | GORMAN KEVIN CHARLES · director | Sale | 7,527 | $12 |
| Jun 17, 2026 | RANIERI RICHARD J · director | Sale | 5,474 | $12 |
| Apr 13, 2026 | Cornelissen Bart Jan · officer: SR. VICE PRESIDENT & CFO | Sale | 3,499 | $12 |
| Mar 9, 2026 | Eckert Celia · officer: SVP, GENERAL COUNSEL | Sale | 1,767 | $11 |
| Mar 9, 2026 | Desjarlais John R · officer: SR. VICE PRESIDENT & CSO | Sale | 2,502 | $11 |
| Mar 9, 2026 | Eckert Celia · officer: SVP, GENERAL COUNSEL | Sale | 3,244 | $11 |
| Mar 9, 2026 | Cornelissen Bart Jan · officer: SR. VICE PRESIDENT & CFO | Sale | 2,517 | $11 |
| Mar 9, 2026 | Desjarlais John R · officer: SR. VICE PRESIDENT & CSO | Sale | 4,118 | $11 |
| Mar 9, 2026 | Dahiyat Bassil I · director, officer: PRESIDENT & CEO | Sale | 14,870 | $11 |
| Mar 9, 2026 | Dahiyat Bassil I · director, officer: PRESIDENT & CEO | Sale | 6,606 | $11 |
| Mar 4, 2026 | Eckert Celia · officer: SVP, GENERAL COUNSEL | A-Award | 18,680 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 59Increased 151Reduced 128Sold out 26
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 13,651,261 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 13,035,918 | May 13, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | Increased | 10,338,022 | May 11, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | Reduced | 10,181,322 | Aug 14, 2026 |
| BVF INC/IL | Unchanged | 7,133,720 | May 15, 2026 |
| BVF INC/IL | Unchanged | 7,133,720 | Aug 14, 2026 |
| RTW INVESTMENTS, LP | Unchanged | 6,777,461 | May 15, 2026 |
| RTW INVESTMENTS, LP | Unchanged | 6,777,461 | Aug 14, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Increased | 5,274,274 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 4,954,016 | Aug 7, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | New Position | 4,897,237 | May 15, 2026 |
| STATE STREET CORP | Reduced | 4,352,036 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 3,500,342 | May 8, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 3,278,802 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 3,101,647 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 8, 2026